Zacks Research Analysts Increase Earnings Estimates for CVSA

Adtalem Global Education Inc. (NYSE:CVSAFree Report) – Equities research analysts at Zacks Research boosted their Q3 2027 earnings per share (EPS) estimates for Adtalem Global Education in a research note issued to investors on Thursday, August 20th. Zacks Research analyst Team now anticipates that the company will earn $2.35 per share for the quarter, up from their previous forecast of $2.13. The consensus estimate for Adtalem Global Education’s current full-year earnings is $9.00 per share. Zacks Research also issued estimates for Adtalem Global Education’s FY2027 earnings at $8.98 EPS.

Adtalem Global Education (NYSE:CVSAGet Free Report) last posted its earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The business had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS.

Other equities analysts have also issued research reports about the stock. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a report on Wednesday, August 19th. Truist Financial increased their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Adtalem Global Education has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Read Our Latest Stock Report on Adtalem Global Education

Adtalem Global Education Stock Performance

Shares of NYSE CVSA opened at $137.01 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. Adtalem Global Education has a 52-week low of $86.97 and a 52-week high of $156.26. The company has a 50 day simple moving average of $126.24. The firm has a market cap of $4.66 billion, a PE ratio of 19.46, a P/E/G ratio of 0.98 and a beta of 0.62.

Hedge Funds Weigh In On Adtalem Global Education

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new stake in Adtalem Global Education Inc. (NYSE:CVSAFree Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is owned by institutional investors.

Insider Buying and Selling at Adtalem Global Education

In other news, SVP Douglas G. Beck sold 4,526 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $135.81, for a total value of $614,676.06. Following the transaction, the senior vice president owned 28,544 shares in the company, valued at approximately $3,876,560.64. The trade was a 13.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 2,186 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $135.15, for a total transaction of $295,437.90. Following the completion of the transaction, the chief financial officer owned 48,306 shares in the company, valued at $6,528,555.90. This trade represents a 4.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 25,951 shares of company stock valued at $3,470,783. 2.50% of the stock is currently owned by company insiders.

About Adtalem Global Education

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

Featured Articles

Earnings History and Estimates for Adtalem Global Education (NYSE:CVSA)

Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.